Previous studies have confirmed that enhanced mitophagy mediated by high PINK1 expression can significantly enhance the sensitivity of hepatocellular carcinoma cells to radiotherapy [42] and lenvatinib [43]. Here, PINK1 is linked to hepatocellular carcinoma.